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Abstract 
The rise of diabetes in Kenya presents many challenges to a healthcare system struggling to deal with communicable diseases 
such as HIV and malaria. The lack of a proper system in place to quickly and effectively diagnose diabetes, especially in remote 
areas, has led to many preventable complications and a rapid increase in diabetes-related hospital admissions. Based on a review 
of literature and governmental reports, as well as fieldwork conducted in Nyeri, Kenya, this article describes patient screening 
and diagnosis pathways. The diverse human factors, technology challenges and systemic issues that impede the timely and 
widespread screening of diabetics are described in details. An understanding of the patient landscape and specific failure modes 
can inform technological, business and policy innovations to lower barriers to diabetes screening, diagnosis and management. 
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1. Introduction 
Non-communicable diseases (NCDs), such as diabetes are a growing global problem.  They are the leading cause 
of death in the world and their increasing prevalence disproportionately affects low-income countries. In Kenya, 
more than half of all hospitalizations can be attributed to NCDs.1 Of these cases, 80% of deaths result from 
diabetes.2 More than 52 million Kenyans are expected to die of diabetes by 20303, far exceeding the combined 
deaths of communicable and nutritional diseases.1 This increasing number of hospitalizations resulting from 
preventable complications of diabetes adds to existing pressures on scarce medical personnel and resources. A major 
challenge in Kenya is lowering barriers to early diagnosis so that the number of preventable hospitalizations can be 
minimized. 
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Addressing this problem has become a daunting challenge in Kenya, where diagnostic tools for diabetes are often 
unaffordable or inaccessible. Government resources are overwhelmingly allocated towards HIV and malaria, leaving 
insufficient funding for diabetes education and outreach.4 Diabetics are often diagnosed only when serious 
complications arise, including ulceration, retinopathy, nephropathy, neuropathy, and cardiovascular disease, which 
puts additional strain on an already strained health ecosystem.  A significant number of cases go unreported due to 
lack of education and access to diagnostic tools. Diagnosed patients account for only 27% of actual diabetes cases in 
Kenya.1 Many undiagnosed patients are from rural areas where the rate of diagnosis is less than half of that in urban 
areas.5 This disturbingly low diagnosis rate is the result of the health care system’s inability to provide accessible 
tools. Affordability, distance to health care facilities, and lack of education are key impediments to obtaining 
diagnoses that are timely and accurate. 
This article discusses the current challenges in diagnosing diabetes as well as the scope of the broader problem in 
Kenya. Field research conducted in Nyeri, Kenya, focusing on issues surrounding diabetes patient pathways in rural 
and remote communities, is used to introduce specific failure modes in diagnosis. During this research in Nyeri, 249 
people were interviewed, including 150 community health workers (CHWs), 8 nurses, 10 chemists (pharmacists), 
and 92 local diabetic community members. The data compiled, in addition to previous literature, will illustrate the 
nature of the problem and areas of weakness in the health care system that would need to be addressed for the 
broader diabetes problem to be mitigated. An understanding of the patient landscape and specific failure modes can 
inform technological, business and policy innovations to lower barriers to diabetes screening, diagnosis and 
management. 
2. Background 
Lowering barriers to early diagnosis of diabetes is an important goal in fighting the disease. However, the current 
barriers in place result from a wide variety of sources, such as insufficient government and international response 
and failure of specific diagnostic devices. These issues must all be addressed in order to provide for widespread 
access to early diagnosis. 
2.1. Overview of Health Care Resources to Diabetes 
Although diabetes and other NCDs have been responsible for a rapidly increasing percentage of deaths in Sub-
Saharan Africa, international and government programs have yet to adapt. While HIV/AIDS relief totaled $726 
million USD in Kenya alone in 2010,6 total international assistance for NCDs worldwide was only $185 million.7 
In 2010, public expenditures for diabetes in Kenya were less than $25,000 USD, and are expected to only double by 
2030.8 The Kenyan Ministry of Health has recently made it a goal to tackle the issue of NCDs, yet the health care 
system is not structured and funded adequately in order to realize this goal. Proper diagnostic resources are still 
desperately needed in many areas in order to achieve an effective response to the disease. 
2.2. Overview of Diagnostic Tools for Diabetics 
Study participants identified many tools being used in Kenya to diagnose diabetes, though most are inaccessible 
to a substantial portion of the population, for both initial screenings and monitoring purposes. 
1. Blood Glucometers- Blood Glucometers measure the instantaneous concentration of glucose in the blood. In 
the United States, they are used by diabetics to monitor their blood sugar multiple times per day to dictate when 
medication should be taken and to record the severity of their condition over a long period of time. In resource-
constrained contexts, glucometers are also used for diagnosis. This is not an entirely accurate method, as extreme 
fluctuations in blood sugar throughout the day can cause false positives or false negatives. As a monitoring tool, this 
method is inaccessible to many patients in sub-Saharan Africa because both the device and the strips are 
prohibitively expensive.9 The cost of each test to the patient is approximately 100 KSh ($1.20USD), about a third of 
the average Kenyan daily wage. 
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2. HbA1c- The glycated hemoglobin (or HbA1c) test is a powerful tool in diabetes diagnosis because it 
indicates long-term glucose levels independent of short-term fluctuations. However, the high cost of the test, 
approximately 1,000 KSh ($12.00 USD), is a significant obstacle to improving glycemic control in diabetic 
patients 10.  
3. Urinalysis- Urinalysis measures levels of glucose and ketones found in the urine. Although urinary glucose 
is a less ideal marker for the diagnosis of diabetes than blood glucose, it has been known to be an effective 
substitution when blood glucose testing is impractical, as in the case of hemophiliacs. However, it cannot 
assess instantaneous levels of hyperglycemia or hypoglycemia, which has led healthcare providers to caution 
against use of the test as a monitoring tool.11 Monitoring ketones, often present in the urine of untreated 
diabetics, yields mixed results for screening diabetes. Nonetheless, the American Diabetes Association has 
asserted that testing for urinary ketones is important for monitoring ketoacidosis for individuals with type I 
diabetes,12 which can be fatal, especially in resource constrained environments 13. While urinary dipstick tests 
have their limitations for adequate prognosis of diabetes, it is an effective screening solution for diabetic 
individuals who do not display any symptoms14,15. Urinalysis screenings are available in most hospitals and 
major clinics for 200KSh ($2.40USD). 
3. Patient Landscape for Diabetics 
Addressing failure modes in diagnosis requires understanding these problems from the patient perspective. If the 
ultimate goal is to make it easier for a patient to receive an accurate diagnosis, each step of this patient landscape 
can provide key insights into how the current system can fail. Figure 1 shows the various steps diabetics might take 
once symptoms arise, with each option thoroughly explained below.  This landscape was developed after extensive 
interviews with patients, doctors, nurses, and other health care workers. 
 
3.1 Do Nothing 
 
In many cases, a patient exhibiting classic symptoms may not seek any form of medical treatment. This decision 
could be for a variety of reasons, including a lack of diabetes awareness, inability to travel the long distances to 
healthcare facilities, and the high cost of diagnostics. Patients who do not seek treatment are more likely to develop 
serious symptoms, which may explain the high rate of diabetic hospitalization. Out of 92 patients surveyed at the 
Othaya District Hospital, a small local hospital outside of Nyeri, 11 were only diagnosed after noticing severe foot 
ulcers that would not heal. Foot ulcers, affecting roughly 5% of diabetics in Nairobi16 are an indication of poor or 
absent disease management. These patients exhibited other symptoms such as excessive thirst and urination as well 
as fatigue but chose to do nothing at first.  
 
3.2 Go to Hospital or Clinic 
 
According to one local medical doctor, when a patient decides to seek health care, they have two primary 
options: hospital or clinic. A hospital could be public, which is government operated and relatively inexpensive, or 
private, which charges more but has better tools available. While the hospitals in rural Kenya appeared well 
equipped to diagnose diabetes, some clinics are extremely small and offer no services to directly screen for or 
diagnose the disease. Two of the eleven clinics investigated in this study did not offer blood glucometer nor 
urinalysis tests. These clinics were forced to either diagnose based on symptoms alone or send patients to a more 
well-equipped facility.  
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Figure 1: Potential pathways for diabetic patients 
 
 
The hospitals in this study offered three different diagnostic tools for potential diabetics. The first is a blood 
glucometer reading, which depending on the circumstances is either taken at random or after fasting. Patients below 
5.6 mmol/dL may be labelled as pre-diabetics, those between 5.6 and 10 mmol/dL are diagnosed with diabetes, and 
those above 10 mmol/dL are diagnosed and immediately admitted for treatment. All patients receive some form of 
disease management counselling and are invited back for weekly workshops, with diagnosed patients also receiving 
medication (most commonly metformin or glibenclamide). The second tool available at hospitals is a urinalysis. 
Nonspecific test strips with ten common urinary parameters are used, though only glucose and ketone level readings 
are considered for diabetes diagnosis. Finally, hospitals offer HbA1c readings, the most common form of diabetes 
diagnosis in the United States, though this option costs $12 USD. Because of this price, this test is too expensive and 
is rarely used. The Provincial General Hospital in Nyeri reported administering 1200 blood glucometer readings in 
the previous month as well as 1550 diabetes urinalysis screenings and 40 HbA1c tests in the previous 3 months.  
The blood glucometer is a popular option, and, despite its relative inaccuracy as an indicator for diabetes, is a 
crucial tool in this context. As urinalysis testing is also widely used, increased availability of either of these two 
tools at local clinics would allow for increased diagnoses. 
 
3.4 Go to Community Health Worker (CHW) 
 
Patients may choose to see a CHW, or CHWs might visit patients as part of their responsibility to look out for 
the health of their neighbours. Of the 150 CHWs who had seen at least one diabetic patient, every one said that a 
patient exhibiting classic symptoms of diabetes would be sent to the nearest health-care facility. All health workers 
surveyed also indicated that patients generally follow instructions given to them by CHWs. With basic training in 
symptom identification, CHWs can be a key resource in eliminating the number of patients who may choose to 
ignore their symptoms.  
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3.5 Treatment and Management 
 
Once diagnosed, doctors and nurses work with patients to develop behaviours and habits that help manage 
diabetes, such as exercise, proper dieting, stress reduction, and minimization of alcohol consumption. One hospital 
provided weekly seminars where medical students discuss diabetes and methods to manage it with patients. They 
utilize visual displays such as a plate that is divided into slices indicating how much of each food group should be in 
a healthy diet.  
 
4. Challenges 
 
The challenges in diagnosing diabetes stem from a variety of issues, or failure modes, present at every phase of 
the patient landscape. The specific failure modes preventing diagnosis became apparent by using observations from 
health care facilities and the interviews conducted. Any one of these failure modes presented in Figure 2 and 
explained below, can prevent a patient from receiving an accurate diagnosis. 
 
 
Figure 2: Common failure modes in diagnosis of diabetes 
 
 
4.1 Patient: 
1. Distance to caretaker: In remote communities, the distance to the nearest medical facility equipped to deal 
with diabetics can be greater than some patients are able to travel. The cost of transportation and the 
opportunity cost of missing work to seek care can prevent patients from diagnosis. Even after diagnosis, it 
may not feasible to return for regular workshops and checkups as mentioned previously. These sessions 
provide a much-needed service, but most patients are local, and those from remote areas often do not take 
advantage of them.   
2. Income level: The cost of a blood glucometer screening is greater than or equal to a day of earnings for 
many patients at the lowest income levels, leading them to delay screening until symptoms become more 
serious.  
3. Lack of awareness: Initial symptoms of diabetes such as frequent urination and excessive thirst may seem 
like minor symptoms to patients who are uneducated about diabetes, and see in them no justification for 
seeking medical care. 
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4.2 Caretaker: 
1. Lack of training: While CHWs are a helpful community resource, many of them know little about diabetes 
or have incorrect information. Additionally, workers at small clinics are often not properly trained to deal 
with blood, introducing the risk of infection to patients. A lack of appropriately trained health care workers 
in remote areas leaves patients with no other option than a hospital or major clinic. 
2. No access to devices: Not all clinics have access to a working glucometer, and only hospitals and major 
clinics are likely to have equipment that correctly measures the color of urinalysis strips. Without the 
proper equipment, these facilities cannot provide accurate diagnoses. 
 
4.3 Device: 
1. Cost: While the disposable test strips each cost less than $1 USD, the cheapest glucometer devices cost 
over $20 USD, which is greater than the monthly income of many patients surveyed. Due to this high cost, 
poorer patients rely on facilities with access to glucometers for diagnosis as well as for monitoring. Only 
wealthy patients own their own glucose meter. Some patients have their glucose concentrations monitored 
without charge in public health facilities. Others, depending on whether they have pay anywhere from 
$0.20 to $50 USD per month for their monitoring.  
2. Battery and life span: Glucometer batteries last on the order of 2,000 uses, and the actual device is likely to 
fail after two years if not properly stored and cleaned. Additionally, while most blood glucometers can give 
reasonable data on blood glucose, total quality control standards are necessary.17 
3. Usability: When glucose or urinary strips are handled improperly, such as being touched with bare hands, 
the results can be inaccurate. Poorly trained individuals may use these devices in ways that produce 
unreliable results. The use of blood in these tests can also cause the spread of disease if personnel are not 
properly trained and equipped to deal with it safely. 
 
4.4 Test strips:  
1. Cost: Each test strip for either urinalysis or a blood glucometer can cost over $1 USD, which many patients 
cannot afford for regular monitoring or even diagnosis. 
2. Accuracy: With glucose test strips, factors such as altitude and humidity can seriously affect results. Failing 
to account for these factors can result in inaccurate results. Where there is access to a glucometer, most 
blood glucose meters can give reasonable results.18 However, they are susceptible to poor quality control 
due to factors such as improper storage conditions.17 
3. Storage: If kept in high heat or very humid conditions, the test strips may be destroyed or compromised, 
leading to inaccurate result19. In addition, one study which measured the effect of storage conditions on test 
strips found that the effective life span of test strip can be reduced to as little as 3 to 14 days if they are not 
left in a closed container.20 
 
4.5 Government resources: 
1. Funding: While the Kenyan government allocated $726 million USD for HIV/AIDS in 2010, less than 
$100 million was available for diabetes. In 2009, only $29 USD per capita was spent on healthcare in 
Kenya21. Combatting diabetes in Kenya cannot be accomplished without increased resources from the 
government and international donors alike.  At the same time, steps can be taken to benefit from already-
existing resources that could be used more effectively.  In particular, the utilization of HIV diagnosis 
networks by the Ministry of Health to also incorporate diabetes detection would substantially reduce the 
increasing rates of undiagnosed and untreated diabetes cases in the country. 
2. Education initiatives: The low levels of patient awareness and inadequate training of  health care workers 
point to a lack of community education initiatives against the growing diabetes problem; the success of 
Kenya's experience with such initiatives when used to combat HIV suggest they contribute significantly to 
combatting diabetes. 
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4.6 Health care practices: 
1. Readiness to test: Doctors in Kenya and other sub-Saharan African countries will recommend an HIV test 
at the slightest sign of any relevant symptoms. One doctor explained that HIV testing is the most common 
test he runs. If doctors and health care workers were similarly aggressive in testing for diabetes, more cases 
could be diagnosed.  
2. Ill-equipped clinics: Many smaller clinics in rural areas have little to no diagnostic equipment, or do not 
have the resources to safely handle and store bodily fluids necessary for testing. 
 
5. Conclusion 
 
The need for accurate and accessible diagnosis for diabetes is acute, and addressing this need is the first step in 
curbing the rise of the disease. All of the factors outlined above, from technical obstacles to a limited educational 
outreach, would need to be addressed in order to reverse the current diabetes trend by lowering barriers to diagnosis. 
Effective programs have made HIV testing accessible to anybody who wants it, and similar approaches must be 
implemented for diabetes. Tackling the issues of HIV and NCDs are not mutually exclusive.  Accordingly, the 
successful program to combat HIV could be the gift that keeps giving if expanded to incorporate diabetes testing. 
 
Approaches for improving diabetes include increasing resources for community education, improving 
distribution networks in remote areas, and designing affordable and ruggedized tools to screen for diabetes. Patients 
who are more informed may engage in fewer risky behaviors associated with diabetes, will know what symptoms to 
look out for, and will be more likely to seek diagnosis. The earlier a diagnosis is made, the better off the patient will 
be, and the likelihood of preventable complications will be reduced. In addition to the decreased burden on patients, 
wider access to diagnosis will also save scarce medical resources, and increase the quality of life for the nation’s 
hardest to reach patients.  
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